Runx2/core-binding factor β (CBFβ) inhibits the Wnt signaling pathway by inducing sclerostin secretion and is required to modulate the functions of osteoblasts and osteoclasts in metastatic BC cells. This evidence concerns the gene CBFB and breast cancer.